HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $999,000 | +8.5% | 7,920 | +3.4% | 0.02% | +4.3% |
| Q2 2019 | $921,000 | +37.5% | 7,656 | 0.0% | 0.02% | +35.3% |
| Q1 2019 | $670,000 | -9.5% | 7,656 | +3.6% | 0.02% | -19.0% |
| Q4 2018 | $740,000 | -12.6% | 7,392 | 0.0% | 0.02% | +5.0% |
| Q3 2018 | $847,000 | +63.8% | 7,392 | +28.2% | 0.02% | +53.8% |
| Q2 2018 | $517,000 | +22.5% | 5,764 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $422,000 | +26.0% | 5,764 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $335,000 | +56.5% | 5,764 | +20.7% | 0.01% | +50.0% |
| Q3 2017 | $214,000 | +26.6% | 4,774 | +11.3% | 0.01% | +20.0% |
| Q2 2017 | $169,000 | +79.8% | 4,290 | +85.7% | 0.01% | +66.7% |
| Q1 2017 | $94,000 | +1.1% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 2,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |